EEC Council Requests Chance to Present Ephedra Facts

July 26, 2000

1 Min Read
EEC Council Requests Chance to Present Ephedra Facts

WASHINGTON--In an effort to inform the government and public about the facts behind ephedra, a panel of industry experts plans to present an objective and comprehensive assessment to the Food and Drug Administration (FDA). The Ephedra Education Council (EEC), supported primarily by members of the American Herbal Products Association (AHPA), plans to present its findings about ephedra during a two-hour session before FDA's Public Health Service meeting on Aug. 8. The assessment will include information about ephedra's effects on cardiovascular and neurological health.

The EEC consists of seven members with backgrounds in toxicology, neurology, pathology and epidemiology. They plan to present an independent consensus review focusing on the safety of ephedra as a weight loss aid.

"The FDA's previous proposed rule was based primarily on adverse event reporting," said Dr. Stephen Kimmel, the panel's chairman. "The panel's goal is to step back from the emotional impact that reports of adverse events can cause and take a hard and objective look at science." It is not yet known when the FDA will respond to this request. For additional information, visit or

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like